biotech · Solid Tumor Malignancies · FENC
FENNEC PHARMACEUTICALS
FENNEC PHARMACEUTICALS INC.
FENNEC PHARMACEUTICALS is a biotech organization headquartered in Research Triangle Park, USA. It trades on NYSE under ticker FENC. Primary therapeutic focus areas include Solid Tumor Malignancies. NovaPharmaNews links 1
Research Triangle Park, USA HQ
1996 Founded
54 Employees
Public company Type
FENC · NYSE Ticker
Company details
- Status
- Public
- HQ
- Research Triangle Park, USA
- Founded
- 1996
- Employees
- 54
- Programs
- 1
- Drugs
- 1
- Patents
- 8
Pedmark® STS
Phase 2 · small molecule · Solid Tumor Malignancies
Pedmark® STS for Solid Tumor Malignancies is a Phase 2 program (small_molecule) at FENNEC PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).
Internal code STUDY00006997
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- FENNEC PHARMACEUTICALS INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Solid Tumor Malignancies
- Status
- active
- Trials
- 1